Immucell Doubles Profit in 4QT15

Animal health company ImmuCell Corp. (NASDAQ: ICCC) of Portland closed its full-year and fourth quarter 2015 with strong sales, which in turn created a backlog of orders for its First Defense product to prevent diarrhea and dehydration in newborn calves. Total sales increased 22% to $2.7 million in the fourth quarter of 2015 ended Dec. 31 compared to $2.2 million in the same period last year. That marked the 14th consecutive quarter of positive sales growth over the last 21 quarters compared to the same quarters the prior years. Net income in Q4 rose to $289,000, or 9 cents per diluted share, versus net income of $131,000, or 4 cents per diluted share, in 4Q2014. Read full story

Related Posts

UNE undergraduate receives BioME grant to study rare lobster larvae

A University of New England undergraduate student has received a $5,000 grant from the Bioscience Association of Maine (BioME) to fund...

23 May 2024

New initiative unites Maine’s innovators to bolster STEM research and workforce

An $8 million grant from the National Science Foundation will fund a four-year initiative led by the University of Maine to bolster STEM...

15 May 2024

Jackson Lab hires its first-ever chief scientific officer

Jackson Laboratory, based in Bar Harbor, has hired Mary Dickinson, a globally recognized geneticist, developmental biologist, and bioengineer, as executive vice...

13 May 2024